Clinical trial
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
NCT00136734 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00136734 |
|---|---|
| Title | Methylphenidate Treatment for Cocaine Abuse and ADHD - 1 |
| Official title | Methylphenidate Treatment for Cocaine Abuse and ADHD |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity, Cocaine-Related Disorders |
| Intervention type | Drug, Other |
| Interventions | Methylphenidate, placebo |
| Enrollment | 124 |
| Start date | Apr 1, 1998 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | Aug 29, 2005 |
| Last update posted | Apr 23, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: